Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
iRhythm Technologies $661.25 million convertible senior notes offering
The 1.5% convertible senior notes are due 2029
Sabre private exchange
We advised Sabre on its exchange of senior secured notes
Roche Holdings $3.875 billion notes offering
We advised Roche on the Rule 144A / Regulation S offering comprising four tranches of notes
Tandem Diabetes Care $316.25 million convertible senior notes offering
The 1.5% convertible senior notes are due 2029
LivaNova $345 million convertible notes offering and capped call transactions
The 2.5% convertible senior notes are due 2029
GFL Environmental $723.45 million secondary offering
The subordinate voting shares are dual-listed on the NYSE and the Toronto Stock Exchange
TPG $600 million senior notes offering
We advised TPG on its investment-grade notes offering
Sumitomo Mitsui Trust Bank $2.25 billion senior notes offering
We advised Sumitomo Mitsui Trust Bank on the update of its global MTN program and senior notes offering
TPG $400 million debut notes offering
We advised TPG on its inaugural offering of junior subordinated notes
SMFG $1 billion perpetual subordinated notes offering
We advised SMFG on its SEC-registered offering of Additional Tier 1 notes